Study guide

29.2 Anesthesia for the Immunocompromised & Oncology Patient

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

29.2 Anesthesia for the Immunocompromised & Oncology Patient

Key Takeaways Explain This Topic AI

Bleomycin-induced pulmonary fibrosis is potentiated by oxygen, so the inspired oxygen concentration is kept at the lowest tolerable level, classically at or below 30 percent titrated to an SpO2 of 88 to 92 percent.

Cyclophosphamide inhibits plasma cholinesterase and prolongs succinylcholine, while methotrexate toxicity is potentiated by nitrous oxide through inactivation of methionine synthase.

The denervated transplanted heart does not respond to atropine or glycopyrrolate, requires direct-acting agents such as isoproterenol or epinephrine, and is preload dependent because it cannot mount a reflex tachycardia.

Lambert-Eaton myasthenic syndrome improves with repeated effort, unlike myasthenia gravis, and confers extreme sensitivity to both depolarizing and nondepolarizing neuromuscular blockers.

Adrenal suppression is assumed after more than 5 mg of prednisone equivalent daily for over 3 weeks within the past year, and unexplained refractory intraoperative hypotension in such a patient suggests addisonian crisis.

Last updated: August 2026

Why This Topic Matters on the NCE

Domain IV.B.6 of the content outline is immune compromised and oncology patients , with three sub-topics: pharmacology, anesthesia techniques and procedures, and management. This population is growing fast, and the anesthetic hazards are almost entirely predictable from two questions: what is suppressing the immune system , and which chemotherapy or radiation has this patient received .

1. Sources of Immune Compromise

  • Cause Anesthetic implication
  • Chemotherapy-induced neutropenia Infection risk with every invasive procedure; thrombocytopenia and anemia
  • Solid organ transplant immunosuppression Drug interactions, nephrotoxicity, denervated organ physiology
  • Chronic corticosteroids Hypothalamic-pituitary-adrenal axis suppression, poor wound healing, fragile skin

Biologic agents (TNF-alpha inhibitors, rituximab, JAK inhibitors) Increased infection risk, sometimes held before surgery

  • HIV infection Antiretroviral drug interactions, neuropathy, marrow suppression
  • Asplenia Overwhelming encapsulated-organism sepsis
  • Diabetes, chronic kidney disease, malnutrition, advanced age Functional immune impairment
  • Neutropenia

An absolute neutrophil count below 1,500 cells per microliter defines neutropenia; below 500 is severe and confers substantial infection risk.

Meticulous aseptic technique for every line, block, and airway manipulation.

Avoid nasal intubation and rectal temperature probes where mucosal breach can seed bacteremia.

Neuraxial and deep blocks require careful risk-benefit judgment in the neutropenic or bacteremic patient; epidural abscess is catastrophic in a patient who cannot mount a response.

Febrile neutropenia is a medical emergency requiring immediate broad-spectrum antibiotics — do not delay them for the operation.

Consider protective isolation and dedicated equipment.

Corticosteroid stress coverage

Adrenal suppression should be assumed in a patient who has taken more than about 5 mg of prednisone equivalent daily for more than 3 weeks within the past year .

  • Surgical stress Typical supplementation
  • Minor (hernia, superficial) Usual morning dose, or hydrocortisone 25 mg

Moderate (open cholecystectomy, joint replacement) Hydrocortisone 50 to 75 mg on the day, tapering over 1 to 2 days

Major (cardiothoracic, major abdominal) Hydrocortisone 100 to 150 mg per day for 2 to 3 days

Undertreatment risks addisonian crisis — refractory hypotension unresponsive to fluids and vasopressors, hypoglycemia, hyponatremia, and hyperkalemia. It should be considered in any unexplained refractory intraoperative hypotension in a steroid-exposed patient.

2. The Transplant Recipient Returning for Unrelated Surgery

Continue immunosuppression uninterrupted , converting to intravenous formulations if necessary.

Drug Key toxicity relevant to anesthesia

Tacrolimus, cyclosporine Nephrotoxicity, hypertension, hypomagnesemia, hyperkalemia, tremor and seizures ; narrow therapeutic index with many interactions

  • Mycophenolate Marrow suppression, gastrointestinal effects
  • Sirolimus Impaired wound healing , pneumonitis, hyperlipidemia
  • Corticosteroids Stress coverage as above
  • Denervated organ physiology

The transplanted heart is denervated and this changes everything about hemodynamic management:

No vagal tone. The resting heart rate is high, typically 90 to 110.

Atropine and glycopyrrolate are ineffective for bradycardia — there is no vagus to block.

Only direct-acting agents work : isoproterenol, epinephrine, dobutamine. Ephedrine's indirect component is lost, so its effect is attenuated and unreliable.

The heart is preload dependent and responds to hypovolemia by falling cardiac output rather than by increasing rate, because there is no reflex tachycardia. Maintain preload.

The ECG may show two P waves if the native atrial remnant is retained.

Silent ischemia — the patient does not experience angina; suspect coronary allograft vasculopathy.

The transplanted lung is also denervated below the anastomosis: absent cough reflex, impaired mucociliary clearance, and disrupted lymphatics that make the lung intolerant of fluid overload. Advance any tube or bronchoscope carefully past the anastomosis, which may be stenotic or friable.

3. HIV Infection

Protease inhibitors, especially ritonavir, are potent CYP3A4 inhibitors and markedly prolong midazolam and fentanyl congeners. Anticipate prolonged sedation.

Non-nucleoside reverse transcriptase inhibitors such as efavirenz induce CYP enzymes — the opposite direction.

Avoid meperidine ; its metabolite normeperidine accumulates and is proconvulsant, and interactions are unpredictable.

Document any preexisting peripheral neuropathy — both HIV itself and several antiretrovirals cause it — before any regional technique.

Check the CD4 count and viral load for a sense of immune reserve; standard precautions apply universally regardless.

Zidovudine causes marrow suppression; several agents cause lactic acidosis and mitochondrial toxicity.

4. Chemotherapy Organ Toxicity: The High-Yield Table

This is the single most testable content in the section.

Agent Toxicity Direct anesthetic consequence

Bleomycin Pulmonary fibrosis, oxygen-potentiated Use the lowest tolerable FiO2 - classically at or below 30 percent, titrated to an SpO2 of about 88 to 92 percent. Avoid fluid overload

Doxorubicin and other anthracyclines Dose-dependent cardiomyopathy , cumulative dose above 550 mg/m2 (lower with mediastinal radiation) Obtain an echocardiogram; treat as heart failure

Cyclophosphamide Inhibits plasma cholinesterase ; hemorrhagic cystitis; SIADH Prolonged succinylcholine and mivacurium

Cisplatin Nephrotoxicity, ototoxicity , peripheral neuropathy, magnesium and potassium wasting Renal dosing; document neuropathy; check electrolytes

Vincristine and vinca alkaloids Peripheral and autonomic neuropathy , SIADH Document neuropathy before regional; autonomic instability

Methotrexate Hepatic, renal, and marrow toxicity; mucositis Avoid nitrous oxide - it inactivates methionine synthase and potentiates methotrexate toxicity

  • 5-fluorouracil Coronary vasospasm and cardiotoxicity, cerebellar toxicity Consider ischemia in chest pain
  • Trastuzumab Cardiomyopathy, often reversible Echocardiographic assessment

Bevacizumab Impaired wound healing , hypertension, bleeding, bowel perforation Typically held 4 to 6 weeks around surgery

Immune checkpoint inhibitors (nivolumab, pembrolizumab) Immune-related adverse events : myocarditis, pneumonitis, colitis, hypophysitis with adrenal insufficiency , thyroiditis Consider occult adrenal insufficiency and myocarditis

  • CAR-T cell therapy Cytokine release syndrome, neurotoxicity Distributive shock picture
  • Radiation effects

Neck irradiation produces fibrosis and immobility that make a previously easy airway difficult — a major difficult-airway predictor.

Mediastinal irradiation causes accelerated coronary disease, constrictive pericarditis, valvular disease, conduction abnormalities, and radiation pneumonitis, sometimes decades later.

Carotid stenosis after neck irradiation.

Xerostomia and mucositis.

5. Oncologic Syndromes the CRNA Must Recognize

Anterior mediastinal mass — the highest-consequence oncologic emergency in anesthesia. Covered in detail in the neck and lymph node section: maintain spontaneous ventilation, avoid neuromuscular blockade, prefer biopsy under local anesthesia, and have rigid bronchoscopy, repositioning, and femoral bypass standby available.

Lambert-Eaton myasthenic syndrome — a paraneoplastic syndrome of small cell lung cancer caused by antibodies to presynaptic voltage-gated calcium channels. Strength improves with repeated effort , the opposite of myasthenia gravis. Patients are markedly sensitive to both depolarizing and nondepolarizing neuromuscular blockers , and anticholinesterases are unreliable.

Superior vena cava syndrome — facial and upper limb edema, distended veins; use lower limb intravenous access , elevate the head, and anticipate airway edema and a difficult airway.

Tumor lysis syndrome — hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia, and acute kidney injury after cytotoxic therapy in a bulky tumor.

Hypercalcemia of malignancy — dehydration, altered mental status, shortened QT, and unpredictable neuromuscular blocker response.

Ectopic ACTH production — Cushingoid features with prominent hypokalemic alkalosis.

Regional anesthesia and cancer recurrence

An attractive hypothesis holds that regional anesthesia, by reducing opioid and volatile exposure and blunting the surgical stress response, might reduce cancer recurrence. Large randomized trials, including the multicenter breast cancer paravertebral block trial, have not demonstrated a difference in recurrence. Choose regional anesthesia for its established analgesic and recovery benefits, not on a recurrence claim.

Exam Traps

Bleomycin means low FiO2. Titrate to 88 to 92 percent, do not give routine high-flow oxygen.

Cyclophosphamide prolongs succinylcholine by inhibiting plasma cholinesterase.

Avoid nitrous oxide with methotrexate.

A denervated heart does not respond to atropine. Use direct-acting agents and maintain preload.

Lambert-Eaton improves with exercise and is exquisitely sensitive to all neuromuscular blockers.

A radiated neck is a difficult airway.

Loading diagram... Chemotherapy Toxicity: What Changes Your Anesthetic